Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$5.61B
-
Value change
-
+$314M
-
Put/Call ratio
-
1.29
-
Number of buys
-
153
-
Number of sells
-
-107
-
Price
-
$267.04
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q1 2024
340 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q1 2024.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 22.2M outstanding shares and own 94.66% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.6M shares), BAKER BROS. ADVISORS LP (1.97M shares), Avoro Capital Advisors LLC (1.94M shares), PAULSON & CO. INC. (1.78M shares), VANGUARD GROUP INC (1.67M shares), BlackRock Inc. (1.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (803K shares), FMR LLC (714K shares), STATE STREET CORP (625K shares), and PERCEPTIVE ADVISORS LLC (430K shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.